Literature DB >> 28260079

Tumor-associated macrophages favor C26 murine colon carcinoma cell proliferation in an oxidative stress-dependent manner.

Lavinia Luput1, Emilia Licarete1, Alina Sesarman1, Laura Patras1, Marius Costel Alupei1, Manuela Banciu1.   

Abstract

The role of tumor-associated macrophages (TAMs) in the development of colon carcinoma is still controversial. Therefore, the present study aimed to investigate the TAM‑driven processes that may affect colon cancer cell proliferation. To achieve this purpose, murine macrophages were co-cultured with C26 murine colon carcinoma cells at a cell density ratio that approximates physiological conditions for colon carcinoma development in vivo. In this respect, the effects of TAM-mediated angiogenesis, inflammation and oxidative stress on the proliferative capacity of C26 murine colon carcinoma cells were studied. To gain insight into the TAM-driven oxidative stress, NADPH oxidase, the main pro-oxidant enzyme in macrophages, was inhibited. Our data revealed that the stimulatory effects of TAMs on C26 cell proliferation may be related mainly to their pro-oxidant actions exerted by NADPH oxidase activity, which maintains the redox status and the angiogenic capacity of the tumor microenvironment. Additionally, the anti-inflammatory and pro-angiogenic effects of TAMs on tumor cells were found to create a favorable microenvironment for C26 colon carcinoma development and progression. In conclusion, our data confirmed the protumor role of TAMs in the development of colon carcinoma in an oxidative stress-dependent manner that potentiates the angiogenic capacity of the tumor microenvironment. These data may offer valuable information for future tumor-targeted therapies based on TAM 're-education' strategies.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28260079     DOI: 10.3892/or.2017.5466

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  11 in total

1.  Liposomal prednisolone phosphate potentiates the antitumor activity of liposomal 5-fluorouracil in C26 murine colon carcinoma in vivo.

Authors:  Laura Patras; Bianca Sylvester; Lavinia Luput; Alina Sesarman; Emilia Licarete; Alina Porfire; Dana Muntean; Denise Minerva Drotar; Alexandra Doina Rusu; Andras-Laszlo Nagy; Cornel Catoi; Ioan Tomuta; Laurian Vlase; Manuela Banciu; Marcela Achim
Journal:  Cancer Biol Ther       Date:  2017-07-11       Impact factor: 4.742

Review 2.  EV-Mediated Chemoresistance in the Tumor Microenvironment: Is NF-κB a Player?

Authors:  Mauro Di Vito Nolfi; Davide Vecchiotti; Irene Flati; Daniela Verzella; Monica Di Padova; Edoardo Alesse; Daria Capece; Francesca Zazzeroni
Journal:  Front Oncol       Date:  2022-06-22       Impact factor: 5.738

3.  Active Tumor-Targeting Nano-formulations Containing Simvastatin and Doxorubicin Inhibit Melanoma Growth and Angiogenesis.

Authors:  Giorgiana Negrea; Valentin-Florian Rauca; Marta Szilvia Meszaros; Laura Patras; Lavinia Luput; Emilia Licarete; Vlad-Alexandru Toma; Alina Porfire; Dana Muntean; Alina Sesarman; Manuela Banciu
Journal:  Front Pharmacol       Date:  2022-04-05       Impact factor: 5.988

4.  Combination therapy of simvastatin and 5, 6-dimethylxanthenone-4-acetic acid synergistically suppresses the aggressiveness of B16.F10 melanoma cells.

Authors:  Valentin-Florian Rauca; Emilia Licarete; Lavinia Luput; Alina Sesarman; Laura Patras; Paul Bulzu; Elena Rakosy-Tican; Manuela Banciu
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

Review 5.  Caffeine and its main targets of colorectal cancer.

Authors:  Wen-Qi Cui; Shi-Tong Wang; Dan Pan; Bing Chang; Li-Xuan Sang
Journal:  World J Gastrointest Oncol       Date:  2020-02-15

Review 6.  Roles of Reactive Oxygen Species in Biological Behaviors of Prostate Cancer.

Authors:  Chenglin Han; Zilong Wang; Yingkun Xu; Shuxiao Chen; Yuqing Han; Lin Li; Muwen Wang; Xunbo Jin
Journal:  Biomed Res Int       Date:  2020-09-29       Impact factor: 3.411

7.  In Vivo Double Targeting of C26 Colon Carcinoma Cells and Microenvironmental Protumor Processes Using Liposomal Simvastatin.

Authors:  Lavinia Luput; Emilia Licarete; Denise Minerva Drotar; Andras-Laszlo Nagy; Alina Sesarman; Laura Patras; Valentin Florian Rauca; Alina Porfire; Dana Muntean; Marcela Achim; Ioan Tomuta; Laurian Vlase; Cornel Catoi; Nicolae Dragos; Manuela Banciu
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

Review 8.  Redox control of cancer cell destruction.

Authors:  Csaba Hegedűs; Katalin Kovács; Zsuzsanna Polgár; Zsolt Regdon; Éva Szabó; Agnieszka Robaszkiewicz; Henry Jay Forman; Anna Martner; László Virág
Journal:  Redox Biol       Date:  2018-02-03       Impact factor: 11.799

Review 9.  Therapeutic Approaches Targeting Proteins in Tumor-Associated Macrophages and Their Applications in Cancers.

Authors:  Deyang Wu; Xiaowei Liu; Jingtian Mu; Jin Yang; Fanglong Wu; Hongmei Zhou
Journal:  Biomolecules       Date:  2022-03-02

10.  Exosomal miR-183-5p Shuttled by M2 Polarized Tumor-Associated Macrophage Promotes the Development of Colon Cancer via Targeting THEM4 Mediated PI3K/AKT and NF-κB Pathways.

Authors:  Shangxin Zhang; Deguan Li; Min Zhao; Fei Yang; Changye Sang; Changhong Yan; Zhenjun Wang; Yongxiang Li
Journal:  Front Oncol       Date:  2021-06-25       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.